copper gluconate has been researched along with ferric oxide, saccharated in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| El-Agroudy, A; El-Husseini, A; Hassan, N; Khalil, A; Sabry, A; Salem, A; Sheashaa, H; Sobh, M | 1 |
| Zager, RA | 1 |
| Hörl, WH; Sengölge, G; Sunder-Plassmann, G | 1 |
| Enzmann, H; Langguth, P; Roth, S; Spicher, K | 1 |
| García-Erce, JA; Gómez-Ramírez, S; Muñoz, M | 1 |
| Becker, K; Johnson, AC; Zager, RA | 1 |
| Graham, DJ; Houstoun, M; Kane, RC; Kelman, JA; Levenson, M; Limb, S; MaCurdy, TE; Mott, K; Reichman, ME; Ryan, Q; Sheu, TC; Wang, C; Wernecke, M; Wong, S; Worrall, C; Xie, D | 1 |
2 review(s) available for copper gluconate and ferric oxide, saccharated
| Article | Year |
|---|---|
Intravenous iron therapy: well-tolerated, yet not harmless.
Topics: Anemia; Cytokines; Endothelial Cells; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Gluconates; Hematinics; Humans; Injections, Intravenous; Iron; Iron-Dextran Complex; Kidney Failure, Chronic; Neutrophils | 2005 |
Intravenous iron in inflammatory bowel disease.
Topics: Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Gluconates; Humans; Inflammatory Bowel Diseases; Infusions, Intravenous; Injections, Intraventricular; Iron; Iron-Dextran Complex; Maltose; Treatment Outcome | 2009 |
1 trial(s) available for copper gluconate and ferric oxide, saccharated
| Article | Year |
|---|---|
Parenteral iron therapy in treatment of anemia in end-stage renal disease patients: a comparative study between iron saccharate and gluconate.
Topics: Adult; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Gluconates; Humans; Kidney Failure, Chronic; Male; Parenteral Nutrition; Renal Dialysis | 2005 |
4 other study(ies) available for copper gluconate and ferric oxide, saccharated
| Article | Year |
|---|---|
Parenteral iron treatment induces MCP-1 accumulation in plasma, normal kidneys, and in experimental nephropathy.
Topics: Acute Disease; Animals; Cells, Cultured; Chemokine CCL2; Ferric Compounds; Ferric Oxide, Saccharated; Gene Expression; Glucaric Acid; Gluconates; Humans; Injections, Intravenous; Iron-Dextran Complex; Kidney Cortex; Kidney Diseases; Liver; Male; Mice; Mice, Inbred Strains; Oxidative Stress; Peritoneum; RNA, Messenger | 2005 |
Comparative toxicity and cell-tissue distribution study on nanoparticular iron complexes using avian embryos and HepG2-cells.
Topics: Animals; Body Weight; Carcinoma, Hepatocellular; Cell Line, Tumor; Chick Embryo; Embryo, Nonmammalian; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Gluconates; Hematinics; Humans; Iron-Dextran Complex; Kidney; Liver; Liver Neoplasms; Nanoparticles; Survival Rate; Turkeys | 2008 |
Parenteral iron formulations differentially affect MCP-1, HO-1, and NGAL gene expression and renal responses to injury.
Topics: Acute Kidney Injury; Acute-Phase Proteins; Animals; Blood Urea Nitrogen; Cell Line; Cell Survival; Chemistry, Pharmaceutical; Chemokine CCL2; Disease Models, Animal; Endotoxins; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Gene Expression Regulation; Glucaric Acid; Gluconates; Glycerol; Heme Oxygenase-1; Humans; Injections, Intravenous; Kidney Tubules, Proximal; Lipocalin-2; Lipocalins; Membrane Proteins; Mice; Oncogene Proteins; Oxidative Stress; Proto-Oncogene Proteins; RNA, Messenger | 2010 |
Comparative Risk of Anaphylactic Reactions Associated With Intravenous Iron Products.
Topics: Aged; Anaphylaxis; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Gluconates; Humans; Incidence; Injections, Intravenous; Iron-Dextran Complex; Male; Medicare Part A; Retrospective Studies; Risk; United States | 2015 |